Retirement & Savings Plan for Amgen Mfg., Limited
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

FORM 11-K

(Mark One)

     
x
  ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
   
  For the fiscal year ended December 31, 2003
 
   
OR
 
   
o
  TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 000-12477

RETIREMENT AND SAVINGS PLAN FOR AMGEN
MANUFACTURING, LIMITED

State Road 31, Kilometer 24.6, Juncos, Puerto Rico 00777
(Full title of the plan)

AMGEN INC.

(Name of issuer of the securities held)
     
One Amgen Center Drive, Thousand Oaks, California   91320-1799

 
 
 
(Address of principal executive offices)   (Zip Code)

 


Table of Contents

The Retirement and Savings Plan for
Amgen Manufacturing, Limited

Financial Statements and
Supplemental Schedule

Years ended December 31, 2003 and 2002

Contents

         
    1  
 
       
Audited Financial Statements
       
 
       
    2  
    3  
    4  
 
       
Supplemental Schedule
       
 
       
    8  
 EXHIBIT 23

 


Table of Contents

Report of Independent Registered Public Accounting Firm

Amgen Puerto Rico, Inc., as Named Fiduciary,
  and the Plan Participants of The Retirement
  and Savings Plan for Amgen Manufacturing, Limited

We have audited the accompanying statements of net assets available for benefits of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) as of December 31, 2003 and 2002, and for the related statements of changes in net assets available for benefits for the years then ended. These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2003 and 2002, and the changes in its net assets available for benefits for the years then ended in conformity with U.S. generally accepted accounting principles.

Our audits were performed for the purpose of forming an opinion on the financial statements taken as a whole. The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2003, is presented for purposes of additional analysis and is not a required part of the financial statements but is supplementary information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. This supplemental schedule is the responsibility of the Plan’s management. This supplemental schedule has been subjected to the auditing procedures applied in our audits of the financial statements and, in our opinion, is fairly stated in all material respects in relation to the financial statements taken as a whole.

/s/ ERNST & YOUNG LLP

June 3, 2004

Stamp No. 1967126
affixed to
original of
this report.

1


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Statements of Net Assets Available for Benefits

                 
    December 31,
    2003
  2002
Assets
               
Investments at fair value
  $ 31,971,387     $ 21,292,678  
Contributions receivable
          136,579  
 
   
 
     
 
 
Net assets available for benefits
  $ 31,971,387     $ 21,429,257  
 
   
 
     
 
 

See accompanying notes.

 


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Statements of Changes in Net Assets Available for Benefits

                 
    Years ended December 31,
    2003
  2002
Additions to net assets:
               
Employee contributions
  $ 3,404,996     $ 1,550,850  
Employer contributions
    2,909,214       1,683,078  
Interest and dividend income
    278,468       220,940  
Net realized/unrealized gain
    5,192,707        
 
   
 
     
 
 
Total additions
    11,785,385       3,454,868  
Deductions from net assets:
               
Benefits paid
    1,243,255       629,254  
Net realized/unrealized loss
          3,559,655  
 
   
 
     
 
 
Total deductions
    1,243,255       4,188,909  
 
   
 
     
 
 
Net increase/(decrease)
    10,542,130       (734,041 )
Net assets available for benefits at beginning of year
    21,429,257       22,163,298  
 
   
 
     
 
 
Net assets available for benefits at end of year
  $ 31,971,387     $ 21,429,257  
 
   
 
     
 
 

See accompanying notes.

 


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements

December 31, 2003

1.   Description of the Plan

The following description of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

General

The Plan was established effective May 1, 1992 (amended and restated effective April 1, 1996) as a defined contribution plan covering substantially all domestic employees of Amgen Puerto Rico, Inc. On January 1, 2002, Amgen Manufacturing, Limited (the Company) assumed the responsibilities of the work force of Amgen Puerto Rico, Inc. The Plan, as amended, is intended to qualify under sections 1165(a) and (e) of the Puerto Rico Internal Revenue Code of 1994, as amended (the PR Code), sections 401(a) and 401(k) of the United States Internal Revenue Code of 1986 (the US Code) (see Note 4 – “Income Tax Status”) and section 407(d)(3)(A) of the Employee Retirement Income Security Act of 1974 (ERISA). On January 1, 2002, the name of the Plan was changed from The Retirement and Savings Plan for Amgen Puerto Rico, Inc. to Amgen Manufacturing, Limited, which assumed the responsibilities of the work force of Amgen Puerto Rico, Inc.

Contributions

During 2003 and 2002, participants could elect to contribute up to 10% of their pretax annual compensation (up to a maximum contribution of $8,000). Participants may also contribute amounts representing distributions from other qualified defined benefit or defined contribution plans.

Each pay period, the Company makes a contribution of 100% of the first 5% of eligible compensation contributed by the employee (Matching contribution). In addition, the Company supplements the Matching contribution for all eligible employees, whether or not they have elected to make contributions to the Plan, with a contribution equal to 3% of each eligible employee’s compensation (Core contribution).

Participants select the funds in which their contributions are to be invested, electing among various investment alternatives. Participants may elect for their contributions to be invested in more than one fund; however, no more than 50% of the value of the participant account may be invested in the Amgen Inc. Stock Fund. Participants may transfer amounts among the investment options at any time, subject to certain Securities and Exchange Commission limitations.

 


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

1.   Description of the Plan (continued)

Vesting

Participants are immediately vested with respect to their individual contributions and earnings thereon. Participants become vested in their allocated Company Matching contributions and related earnings at a rate of 25% per year for each of their first four years of service completed.

The Company’s Core contributions and related earnings become 100% vested upon completion of five years of service, with no partial vesting. Generally, employees must work a minimum of 1,000 hours within a Plan year to receive vesting for that year of service. Company contributions become fully vested upon attainment of normal retirement age, disability, or death.

Participant Accounts

Each participant’s account is credited with the participant’s contributions and an allocation of (a) Company contributions and (b) Plan earnings and losses. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account. Forfeited balances of terminated participants’ nonvested accounts during 2003 and 2002 were used to reduce future Company contributions.

Payment of Benefits

Upon termination of service due to death, disability (as defined by the Plan), retirement, or severance from employment, a participant may elect to receive an amount equal to the value of the participant’s vested account balance in either a lump-sum payment in cash and/or full shares of the Company’s common stock. The number of shares of Company common stock to be paid is based on the quoted market value of such stock on the date the Plan is valued following employee notification.

Generally, participants may not make withdrawals of amounts from the Plan while a participant continues to be employed by the Company.

Participant Loans

Subject to the Company’s approval, participants can generally obtain a loan from their account up to the lesser of an amount equal to 50% of the participant’s vested account balance or $50,000, less the highest balance of any outstanding loans within the previous twelve months. The loans bear interest at average borrowing rates of certain major banks (ranging from 7.42% to 12.66%) and are generally payable in installments over periods ranging from one to five years. Principal and interest payments are allocated to the participant’s account.

Plan Termination

Effective as of 12:00 a.m. on January 1, 2004, Amgen Puerto Rico, Inc. transferred all of the assets of the Plan to a new plan, also named The Retirement and Savings Plan for Amgen Manufacturing, Limited. The assets of the Plan were transferred within the same trustee and at the same fund balances as December 31, 2003. Immediately following the transfer, Amgen Puerto Rico, Inc. terminated the Plan.

5


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

1.   Description of the Plan (continued)

Trustee

Banco Santander acts as the Plan’s trustee.

2.   Summary of Significant Accounting Policies

Basis of Accounting

The financial statements have been prepared on the accrual basis of accounting.

Investment Income and Losses

Dividend income is recognized on the ex-dividend date and interest income is recorded on an accrual basis. Unrealized gains and losses on investments are measured by the change in the difference between the fair value and cost of the securities held at the beginning and end of the period. Realized gains and losses from security transactions are recorded based on the weighted-average cost of securities sold.

Investment Valuation

Investments in mutual funds and Amgen Inc. common stock are valued at current market values determined through reference to public market information on the last business day of the Plan year. Participant loans are valued at their outstanding balances, which approximate fair value.

Use of Estimates

The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

3.   Investments

The fair value of individual investments that represent 5% or more of the Plan’s net assets are as follows:

                 
    December 31,
    2003
  2002
Amgen Inc. Common Stock
  $ 13,724,229     $ 9,542,266  
Fidelity Magellan Fund
    4,268,512       2,693,672  
Fidelity Spartan U.S. Equity Index
    2,247,324       1,592,417  
Fidelity OTC Portfolio
    2,249,081       1,410,080  
Fidelity Growth and Income Portfolio
    1,710,968       1,129,172  
 
   
 
     
 
 
 
  $ 24,200,114     $ 16,367,607  
 
   
 
     
 
 

6


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

3.   Investments (continued)

During 2003 and 2002, the Plan’s investments (including gains and losses on investments bought and sold, as well as held during the year) appreciated/(depreciated) in value as follows:

                 
    Year ended December 31,
    2003
  2002
Amgen Inc. Common Stock
  $ 2,591,836     $ (1,469,185 )
Mutual funds
    2,600,871       (2,090,470 )
 
   
 
     
 
 
 
  $ 5,192,707     $ (3,559,655 )
 
   
 
     
 
 

4.   Income Tax Status

In June 1997, the Company received a determination letter from the Puerto Rico Treasury Department, stating that the Plan is qualified, in form, under the PR Code and, therefore, the related trust forming a part of the Plan is exempt from taxation. Once qualified, the Plan is required to operate in conformity with the PR Code to maintain its qualification. The Company received a determination letter from the United States Internal Revenue Service (the IRS) dated April 25, 2000 stating that the Plan is qualified under the US Code. The Company believes the Plan was being operated in compliance with the applicable requirements of the PR Code and the US Code, except for the timely adoption of certain amendments. During 2002, the Plan did not adopt amendments to comply with the Economic Growth and Tax Relief Reconciliation Act of 2001 (the EGTRRA) within the period specified by the IRS. In order to correct this event of noncompliance, the Plan sponsor is in the process of preparing and submitting an application under the Voluntary Compliance Program (the VCP) of the Employee Plans Compliance Resolution System in accordance with the procedures set forth in Revenue Procedure 2002-44. The Plan sponsor will take such corrective action as may be required in connection with the VCP filing to maintain the Plan’s qualified tax-exempt status, including adoption of a good faith EGTRRA amendment within the time period specified in the compliance statement issued by the IRS.

5.   Services Provided by the Company

The Company provides certain administrative and record keeping services for the Plan at no cost to the Plan participants. In addition, the Company has paid the trustee fees and other related costs on behalf of the Plan.

7


Table of Contents

Supplemental Schedule

The Retirement and Savings Plan for Amgen Manufacturing, Limited

EIN: 98-0210484 Plan: 35322

Schedule H, Line 4i – Schedule of Assets (Held at End of Year)

December 31, 2003

             
    Description of   Current
Identity of Issue
  Investment
  Value
Amgen Inc.*
  Common stock 222,086 shares   $ 13,724,229  
 
           
Fidelity Magellan Fund* 
  Mutual fund 43,672 shares     4,268,512  
 
           
Fidelity Growth and Income Portfolio* 
  Mutual fund 48,020 shares     1,710,968  
 
           
Fidelity Retirement Money Market Portfolio*
  Money market portfolio     1,384,005  
 
           
Fidelity Overseas Fund*
  Mutual fund 29,809 shares     936,891  
 
           
Fidelity Spartan U.S. Equity Index*
  Mutual fund 57,024 shares     2,247,324  
 
           
Fidelity Short-Term Bond*
  Mutual fund 132,688 shares     1,199,504  
 
           
Fidelity OTC Portfolio*
  Mutual fund 69,266 shares     2,249,081  
 
           
Fidelity Asset Manager*
  Mutual fund 21,960 shares     346,089  
 
           
Fidelity Asset Manager: Growth*
  Mutual fund 43,422 shares     620,065  
 
           
Fidelity Asset Manager: Income*
  Mutual fund 29,724 shares     361,148  
 
           
Fidelity U.S. Bond Index Portfolio*
  Mutual fund 59,062 shares     660,906  
 
           
Fidelity Contrafund*
  Mutual fund 17,654 shares     871,247  
 
           
Participant loans*
  Interest rates from 7.42 % to 12.66%     1,391,418  
       
 
 
        $ 31,971,387  
 
       
 
 

*Party-in-interest

 


Table of Contents

Signatures

     Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

             
          Retirement and Savings Plan for Amgen
          Manufacturing, Limited
          (Name of Plan)
 
           
Date:
  6/28/04   By:   /s/ Richard D. Nanula
 
 
     
 
          Richard D. Nanula
          Chief Financial Officer
          Amgen Manufacturing, Limited

9


Table of Contents

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Index to Exhibit

     
Consent of Ernst & Young LLP,
   
Independent Registered Public Accounting Firm
  Exhibit 23

 

exv23
 

EXHIBIT 23

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 33-47605) pertaining to The Retirement and Savings Plan for Amgen Manufacturing, Limited of our report dated June 3, 2004, with respect to the financial statements and supplemental schedule of The Retirement and Savings Plan for Amgen Manufacturing, Limited included in this Annual Report (Form 11-K) for the year ended December 31, 2003.

/s/ ERNST & YOUNG LLP

San Juan, Puerto Rico
June 25, 2004